The House of Representatives recently passed a bill this week that continues telehealth use under Medicare through 2024 that was initially authorized during the the height of the COVID-19 pandemic.
The House of Representatives recently passed a bill this week that continues telehealth use under Medicare through 2024 that was initially authorized during the the height of the COVID-19 pandemic.
The bill, H.R. 4040, Advancing Telehealth Beyond COVID-19 Act of 2022, would allow federally qualified health centers and rural health clinics to serve as a site for beneficiaries to receive telehealth services anywhere, regardless of type or location. The bill would allow any type of practitioner to offer CMS approved telehealth services and it would continue coverage for audio-only evaluation and management and behavioral health services.
The continuance follows after many telehealth business models regressed to limited serevices that once existed before the pandemic.
The American Medical Association applauded the passing of the bill that is now moving to the Senate for approval.
AMA President Dr. Jack Resneck Jr. commented on the recent news stating, "Increased Medicare-covered access to telehealth has been a lifeline to patients and physicians throughout the COVID-19 pandemic..."
"The COVID-19 public health emergency made plain that care via telehealth should be available to all Medicare patients, especially with their own physicians, regardless of where they live or how they access these services.
"From continuity of care, broadened access to care, and removing geographic and originating-site restrictions, our hope is that the flexibilities afforded during the public health emergency will be made permanent," he added. "This legislation offers an important step in that direction by extending telehealth benefits to December 31, 2024. We urge the Senate to act on this bipartisan bill, and for the Congress to build on this success."
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Published: November 25th 2024 | Updated: November 25th 2024CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Read More